Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries. Two major risk loci for the disease have been identified: CFH on chromosome 1 and a locus in chromosomal region 10q26. The CFH association clearly implicates the alternative complement pathway in disease, but the chr10q26 locus, spanning the ARMS2 and HTRA1 genes, is the subject of controversy. High linkage disequilibrium in this region prevents elucidation of the causal variant or even which gene influences AMD susceptibility. There are conflicting reports of alterations in transcript or protein levels of both ARMS2 and HTRA1 in AMD, so the issue remains unresolved. In this chapter, HTRA1 – a serine protease with known roles in extracellular matrix (ECM) degradation and TGF® signalling – is evaluated as a candidate gene for regulating susceptibility in AMD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allikmets R, Dean M (2008) Bringing age-related macular degeneration into focus. Nat Genet 40:820–821
An E, Sen S, Park SK et al (2010) Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Invest Ophthalmol Vis Sci 51:3379–3386
Bakay M, Zhao P, Chen J et al (2002) A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord 12:S125–S141
Cameron DJ, Yang Z, Gibbs D et al (2007) HTRA1 Variant Confers Similar Risks to Geographic Atrophy and Neovascular Age-Related Macular Degeneration. Cell Cycle 6:1122–1125
Canfield AE, Hadfield KD, Rock CF et al (2007) HtrA1: a novel regulator of physiological and pathological matrix mineralization? Biochem Soc Trans 35:669–671
Chamberland A, Wang E, Jones AR et al (2009) Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo. J Biol Chem 284:27352–27359
Chowers I, Meir T, Lederman M et al (2008) Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel. Mol Vis 14:2263–2271
Clausen T, Southan C, Ehrmann M (2002) The HtrA Family of ProteasesImplications for Protein Composition and Cell Fate. Mol Cell 10:443–455
De Luca A, De Falco M, Fedele V et al (2004) The serine protease HtrA1 is upregulated in the human placenta during pregnancy. J Histochem Cytochem 52:885–892
Dewan A, Liu M, Hartman S et al (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314:989–992
Edwards AO, Ritter R, Abel KJ et al (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424
Fisher Sa, Abecasis GR, Yashar BM et al (2005) Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet14:2257–2264
Friedman DS, O’Colmain BJ, Muñoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564–572
Fritsche LG, Loenhardt T, Janssen A et al (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40:892–896
Gold B, Merriam JE, Zernant J et al (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38:458–462
Grau S, Richards PJ, Kerr B et al (2006) The role of human HtrA1 in arthritic disease. J Biol Chem 281:6124–6129
Gray CW, Ward RV, Karran E et al (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. FEBS J 267:5699–5710
Hageman GS, Anderson DH, Johnson LV et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102:7227–7232
Haines JL, Hauser Ma, Schmidt S et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419–421
Hara K, Shiga A, Fukutake T et al (2009) Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 360:1729–1739
Hu SI, Carozza M, Klein M et al (1998) Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. J Biol Chem 273:34406–34412
Iyengar SK, Song D, Klein BEK et al (2004) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 74:20–39
Jakobsdottir J, Conley YP, Weeks DE et al (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77:389–407
Kanda A, Chen W, Othman M et al (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A 104:16227–16232
Kanda A, Stambolian D, Chen W et al (2010) Age-related macular degeneration-associated variants at chromosome 10q26 do not significantly alter ARMS2 and HTRA1 transcript levels in the human retina. Mol Vis 16:1317–1323
Klein R, Peto T, Bird A et al (2004) The epidemiology of age-related macular degeneration. Am J Ophthalmol 137:486–495
Klein RJ, Zeiss C, Chew EY et al (2006) Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science 308:385–389
Kortvely E, Hauck SM, Duetsch G et al (2010) ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Invest Ophthalmol Vis Sci 51:79–88
Majewski J, Schultz DW, Weleber RG et al (2003) Age-related macular degeneration--a genome scan in extended families. Am J Hum Genet 73:540–550
Murwantoko, Yano M, Ueta Y et al (2004) Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. Biochem J 381:895–904
Nie G-y, Hampton A, Li Y et al (2003) Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), comparison of its tissue distribution with HtrA1 and HtrA2. Biochem J 371:39–48
Oka C, Tsujimoto R, Kajikawa M et al (2004) HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131:1041–1053
Rivera A, Fisher SA, Fritsche LG et al. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 14(21):3227–3236
Seddon JM, Santangelo SL, Book K et al (2003) A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 73:780–790
Wang G, Spencer KL, Scott WK et al (2010) Analysis of the indel at the ARMS2 3’UTR in age-related macular degeneration. Hum Genet 127:595–602
Weeks DE, Conley YP, Tsai H-J et al (2004) Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 75:174–189
Yang Z, Camp NJ, Sun H et al (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314:992–993
Yang Z, Tong Z, Chen Y et al (2010) Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration. PLoS Genet 6:e1000836
Yates JRW, Sepp T, Matharu BK et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357:553–561
Zumbrunn J, Trueb B (1996) Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 398:187–192
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this paper
Cite this paper
Stanton, C.M., Chalmers, K.J., Wright, A.F. (2012). The Chromosome 10q26 Susceptibility Locus in Age-Related Macular Degeneration. In: LaVail, M., Ash, J., Anderson, R., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 723. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0631-0_47
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0631-0_47
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0630-3
Online ISBN: 978-1-4614-0631-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)